Clinical Trials Directory

Trials / Completed

CompletedNCT01279070

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

Efficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Fundació Sant Joan de Déu · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to develop an integrative intervention for schizophrenia taking into account previous efficacious therapies. Thus, our aim was to evaluate the efficacy of our cognitive remediation group training: Problem Solving and Cognitive Flexibility training (REPYFLEC), focused to improve neurocognition and functioning in schizophrenia patients. We hypothesized that training executive function and metacognition would allow us to achieve improvements in neurocognition, functioning and psychiatric symptoms of patients with schizophrenia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRepyflec cognitive remediation trainingComparison of 32 Repyflec group sessions among 32 leisure group sessions where we stimulated non-specific cognitive perform.

Timeline

Start date
2006-09-01
Primary completion
2009-01-01
Completion
2011-03-01
First posted
2011-01-19
Last updated
2013-08-23
Results posted
2013-08-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01279070. Inclusion in this directory is not an endorsement.

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia (NCT01279070) · Clinical Trials Directory